Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
NCT06087120
·
clinicaltrials.gov ↗
RECRUITING
Status
125
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer Female
Stage II Breast Cancer
Stage III Breast Cancer
HER2-positive Breast Cancer
Triple Negative Breast Cancer
Sponsor
Gene Solutions